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Any experiment, process or action in science aiming to be performed 
with high accuracy and precision requires a careful consideration of 
its underlying uncertainties and potential sources of errors.This most 
essential analysis plays a profound role in planning and evaluation of 
the considered processes and is based on established probabilistic 
concepts that quantify expectation values and variances of the 
quantities of interest. 
Naturally, this general framework applies to the planning and 
evaluation of modern radiation therapy, where geometrical and 
dosimetric accuracy and precision are viewed as key performance 
indicators of a treatment. However, so far the analysis of potential 
treatment uncertainties is mostly limited to the PTV margin concept 
where only the aspect of dose coverage of the CTV is explicitly 
addressed at the early planning stage. This approach neglects dose 
uncertainties to other important tissues, because it heuristically 
accounts just for the expectation value of the prescribed tumor dose 
and furthermore does not provide any information about the variances 
or anticipated ‘error bars’ of any relevant treatment quality indicator. 
The key idea of probabilistic treatment planning is to include the 
known or estimated uncertainties of treatment parameters, mostly 
described and modeled by Gaussian probability densities, directly into 
the treatment planning process and automatically generate dose 
distributions whose expectation value is ‘robust’, i.e. not sensitive to 
the anticipated inherent preparation and execution errors of the 
treatment. This requires sacrificing the PTV concept because 
respective safety zones for the dose of the tumor target will be 
automatically generated. Moreover, the method provides a complete 
analysis of the achieved dose patterns in terms of expectation values 
and their respective variances for a final evaluation of a treatment 
plan. 
Besides a general introduction into the topic we will present various 
concepts of probabilistic treatment planning. A specific focus of the 
talk will be on a new approach of probabilistic analytical Gaussian 
dose calculations that allow an efficient application within standard 
inverse planning concepts. This approach is particularly well suited for 
planning of intensity modulated treatments with photon and proton 
beams and naturally can account for any correlation between the 
considered uncertainties. Several examples of respective treatments 
influenced by various sources of uncertainties will be discussed in 
detail. 
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Modern image-guidance systems permit to efficiently correct set-up 
error through rigid translations and, in few cases, rotations of the 
patient. In the case of daily image guidance and disregarding 
contouring uncertainty, the margin that should actually be applied 
should take into account few residual components such as intra-
fraction changes, the uncertainty of the IGRT system in assessing and 
applying the correction and the uncertainty due to the rigidity of the 
correction (here named: residual deformation  error, RDE). 
In several clinical situations, RDE is prevalent and, due to the 
difficulty in individually predicting GTV/CTV deformations during 
treatment, is difficult to manage and to rationally include in a 
properly defined margin. The scenario may also be influenced by 
shrinkage/progression of the tumour that may be counteracted by 
adaptive strategies. Even in this case, the problem of RDE is still there 
in the different phases of the treatment (before/after adaptive 
corrections). 
When the contour of GTV/CTV is available on a large sample of 
fractions, the probability coverage map of the positions of GTV/CTV, 
after rigid correction,  may be precisely assessed for each single 
patient: in the case of daily imaging, it  represents the “true” 
coverage map. The local 3D distances between the planning GTV/CTV 
and the surface corresponding to a large probability coverage (SX%, 
typically S=90-100%) may be calculated to directly assess “margin 
maps” for each specific patient, intrinsically including systematic 
errors. Starting from this map, a pragmatic and robust approach is to 
split GTV/CTV into sectors (for instance, according to a spherical or a 
cylindrical system) and looking to the margin distribution in each 
sector. A first step is to consider the mean value of the local margins 
within each sector, defined here as the “smoothed sector margin” 
(SSM). If expanding GTV/CTV by SSM to take RDE into account in each 
sector, a fraction of the volume included in SX% is not included in the 
corresponding sector PTV (“Out-SSM volume”, OSV): the impact of OSV 
depends on the spread of the local margins with respect to SSM (the 
SD of the variation of sector local margins). In order to take OSV into 
account, it is reasonable to define a cut-off value below which it may 
be disregarded (for instance 95 or 99% of the GTV/CTV sector 
volume): based on this, an additional margin (named “local-noise 
sector margin”, LNSM) may be added to SSM to include the relevant 
fraction of OSV, according to this cut-off. LNSM may be negligible in 
many cases, depending on the noise of the local deformation, on the 
number/type of sectors and on the GTV/CTV volume. Patient specific 
SSM (and, if the case, LNSM) values may be pooled in a population 
analysis to derive SSMY% (and SSM+LNSMY%) corresponding to those 
values that may guarantee a large (90-100%) fraction of patient to be 
covered.   The method was applied on a sample of 20 patients treated 
for rectal cancer (10 supine and 10 prone in institute A and B 
respectively), considering the motion of the rectum; the analysis was 
repeated for the whole and the second part of the treatment. Rectum 
was split in two halves (cranial-caudal) and each half was split in 4 
equi-spaced sectors, according to a cylindrical segmentation of the 
rectum (in total 8 sectors). SSM corresponding to 90% and 100% 
coverage probability were derived for each sector of each patient; 
then, SSM90% (SSM assuring 90-100% sector coverage in 90% of the 
patients) were derived. For the supine group SSM90% were 
significantly smaller in the second part of the treatment with respect 
to the first one and were in the range 4-7mm. The consistency of SSM 
definition was prospectively confirmed on 20 additional patients 
treated with an adaptive boosting in the last 6 fractions (Figure 1): 
PTV including RDE was adequate for 10 male patients, while was 
slightly insufficient for 2/10 female patients.The suggested method 
can assess population-based margins taking RDE into account; it may 
robustly works especially in the case GTV/CTV or their surrogates may 
be drawn on already available daily in-room CT images.  
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Purpose: Besides the need for consistent dosimetry of proton therapy 
beams worldwide, the measurement of absolute dose for this modality 
is important for a variety of reasons. Ensuring consistency with other 
treatment modalities is particularly important when performing mixed 
treatments such as proton and x-ray therapy as is being applied in 
some hospitals. Consistency with other forms of radiotherapy is evenly 
important for coherent detector perturbation factors and biological 
weighting factors across modalities. 
Methods: The traditional method for measuring the quantity absorbed 
dose according to its definition is calorimetry. No primary standards 
for proton dosimetry currently exist although a number of national 
metrology institutes in Switzerland, Germany, The Netherlands and 
the United Kingdom are working towards such calorimetry-based 
